Home | << 1 >> |
Record | |||||
---|---|---|---|---|---|
Author | Bousingen, Denis Durand de | ||||
Title | Drug firm compensates patients for suspected hepatitis B vaccine failure | Type | Journal Article | ||
Year | 2001 | Publication | The Lancet | Abbreviated Journal | |
Volume | 357 | Issue | 19.05.2001 | Pages | 1598 |
Keywords | health promotion; viral hepatitis; hepatitis B | ||||
Abstract | A French appeal court has ordered GlaxoSmithKline (GSK) to pay US$6686 and US$10 697 in compensation to two women with multiple sclerosis who claim the chronic disease was caused by a hepatitis B vaccine (Engerix B) manufactured by the pharmaceutical company. | ||||
Address | |||||
Corporate Author | Thesis | ||||
Publisher | Place of Publication | Editor | |||
Language | English | Summary Language | Original Title | ||
Series Editor | Series Title | Abbreviated Series Title | |||
Series Volume | Series Issue | Edition | |||
ISSN | 0140-6736 | ISBN | Medium | ||
Area | Expedition | Conference | |||
Notes | Approved | no | |||
Call Number | 50-02698 | Serial | 59735 | ||
Permanent link to this record |